Proteomics
Re-trafficking proteins to fight Salmonella infections
Scientists including members of EMBL’s Typas group have investigated how immune cells called macrophages respond to infection by the intracellular pathogen Salmonella enterica. They discovered that Salmonella causes newly produced cathepsins to accumulate in the nuclei of infected cells to…
Identifying how potential COVID-19 drugs work
EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living cells…
Melting reveals drug targets in a living organism
EMBL scientists identify drug targets in blood and organs…
Decoding ageing
The naked mole-rat as a model organism in ageing research…
ATP affects proteome-wide solubility
Scientists develop technology to measure how ATP concentration affects protein solubility in cells…
Melting bacteria to decipher antibiotic resistance
EMBL scientists investigate how bacteria melt to study their reaction to drugs…
Futures: The dark proteome
ERC grantee Edward Lemke shares his vision for the next ten years…
Futures: Brain evolution
ERC grantee Detlev Arendt shares his vision for the next ten years…
Turning up the heat on drug side effects
Side-effects of leukaemia drug explained, reveal possibility of repurposing to treat other diseases…
Welcome to EMBL: Mikhail Savitski
New head of Proteomics Core Facility also runs stability proteomics lab…
